FDA Adverse Event Injury Summary report: N

AMPLATZER TALISMAN PFO OCCLUDER

MDR report key: 19681413 · Received July 5, 2024

Report

Report Number
2135147-2024-03257
Event Type
Injury
Date Received
July 5, 2024
Date of Event
June 12, 2024
Report Date
August 6, 2024
Manufacturer
ABBOTT MEDICAL
Product Code
MLV
UDI-DI
05415067033314
PMA / PMN Number
P120021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION IS NOT YET COMPLETE. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.

Additional Manufacturer Narrative · 0

AN EVENT OF VASCULAR BLEEDING AFTER SUCCESSFUL IMPLANTATION OF DEVICE WAS REPORTED. INFORMATION FROM FIELD INDICATED THE PATIENT WAS RESUSCITATED AND TRANSFERRED TO VASCULAR SURGEON FOR REPAIR OF EPIGASTRIC VEIN. THERE WERE NO PERFORMANCE ISSUES REPORTED WITH THE ABBOTT DEVICE. A RETURNED DEVICE ASSESSMENT COULD NOT BE PERFORMED AS THE DEVICE REMAINS IMPLANTED AND WAS NOT RETURNED FOR ANALYSIS. THE DEVICE HISTORY RECORD WAS REVIEWED TO ENSURE THAT EACH MANUFACTURING AND INSPECTION OPERATION WAS PERFORMED AND THE PRODUCT MET ALL SPECIFICATIONS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO LABELING DESIGN OR MANUFACTURING OF THE DEVICE.

Description of Event or Problem · 0

IT WAS REPORTED THAT ON (B)(6) 2024, 25-18MM AMPLATZER TALISMAN PFO OCCLUDER WAS SUCCESSFULLY IMPLANTED IN THE PATIENT. AFTER SUCCESSFUL IMPLANTATION OF THE DEVICE, VASCULAR BLEEDING WAS NOTICED. PATIENT RESUSCITATED AND TRANSFERRED TO VASCULAR SURGEON FOR REPAIR OF EPIGASTRIC VEIN. PER THE PHYSICIAN, IT IS SUSPECTED THAT SPONTANEOUS BLEEDING OCCURRED UNDER HEPARIN.THE PATIENT IS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
901910 AMPLATZER TALISMAN PFO OCCLUDER TRANSCATHETER SEPTAL OCCLUDER MLV ABBOTT MEDICAL 10154385 05415067033314

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention